Randomized trial evaluates valve reprogramming outcomes in normal pressure hydrocephalus, indicating potential benefits of new cranial implant technology.
To evaluate whether a valve-agnostic cranial implant allows reliable reprogramming of programmable ventriculoperitoneal (VP) shunt valves in normal pressure hydrocephalus (NPH), and to assess clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Bindra et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: